2C-B-aminorex

Chemical compound
2C-B-aminorex
Identifiers
  • 5-(4-bromo-2,5-dimethoxyphenyl)-4,5-dihydro-1,3-oxazol-2-amine
PubChem CID
  • 165360199
UNII
  • HBY9BQ3YJK
Chemical and physical data
FormulaC11H13BrN2O3
Molar mass301.140 g·mol−1
3D model (JSmol)
  • Interactive image
  • COC1=CC(=C(C=C1C2CN=C(O2)N)OC)Br
InChI
  • InChI=1S/C11H13BrN2O3/c1-15-8-4-7(12)9(16-2)3-6(8)10-5-14-11(13)17-10/h3-4,10H,5H2,1-2H3,(H2,13,14)/t10-/m0/s1
  • Key:XUTCHZHTIDHQOP-JTQLQIEISA-N

2C-B-aminorex (2C-B-AR) is a recreational designer drug with psychedelic effects. It is a substituted aminorex derivative which was first identified in Sweden in June 2019.[1] Structurally, it is a hybrid of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and aminorex.[2]

See also

References

  1. ^ Evans-Brown M, Gallegos A, Christie R, Jorge R, De Morais J, Almeida A, Sedefov R (December 2020). New Psychoactive Substances: Global Markets, Glocal Threats and the COVID-19 Pandemic. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-557-7.
  2. ^ Seibert, Elisabeth; Kunert, Olaf; Pferschy-Wenzig, Eva-Maria; Schmid, Martin G. (Jan 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18): 5770. doi:10.3390/molecules27185770. ISSN 1420-3049. PMC 9503756. PMID 36144500.


  • v
  • t
  • e